Lung Cancer Archives - Page 2 of 2

Osimertinib for EGFR Mutation (T790M): Complete Patient Guide

Leave a Comment / Blog, EGFR, Lung Cancer, Osimertinib / Admin

Introduction For many patients with EGFR-mutated non-small cell lung cancer (NSCLC), targeted therapy has transformed treatment outcomes. Earlier EGFR inhibitors helped many patients control their cancer for months or even years. However, over time, some cancers develop resistance, making these medicines less effective. One of the most common resistance mechanisms is the EGFR T790M mutation. […]

Osimertinib for EGFR Mutation (T790M): Complete Patient Guide Read More »

The Hidden Cost of Cancer: More Than Just Medical Bills

Leave a Comment / Blog, Lung Cancer, Osimertinib, Patient Guide / Admin

Introduction When someone is diagnosed with cancer, the first concern is naturally their health. Questions about treatment, recovery, and survival quickly take center stage. But for millions of patients and families worldwide, another battle begins almost immediately—the hidden financial and emotional cost of living with cancer. Cancer is not only a medical condition. It is

The Hidden Cost of Cancer: More Than Just Medical Bills Read More »

Osimertinib Resistance — Causes and What Happens Next

Leave a Comment / Blog, EGFR, Lung Cancer / Admin

For patients doing well on Osimertinib, the possibility that it might eventually stop working can be a source of anxiety. This is a valid concern — like most targeted cancer therapies, Osimertinib resistance can develop over time. This guide explains why resistance happens, how it is detected, and importantly, what treatment options exist afterward. Understanding

Osimertinib Resistance — Causes and What Happens Next Read More »

Named Patient Medicine Explained — How Patients Legally Access Unavailable Medicines

Leave a Comment / Blog, Lung Cancer / Admin

If you have been researching how to access a medicine like Osimertinib that isn’t available or affordable in your country, you have likely come across the term “Named Patient Medicine.” This guide explains exactly what it means, why it exists, and how it works in practice. What is Named Patient Medicine? Named Patient Medicine (NPM)

Named Patient Medicine Explained — How Patients Legally Access Unavailable Medicines Read More »

Osimertinib and Brain Metastasis — What the Research Shows

Leave a Comment / Blog, EGFR, Lung Cancer / Admin

For patients with EGFR-mutated NSCLC, one of the most worrying possibilities is that the cancer could spread to the brain. Brain metastases occur in a significant proportion of advanced lung cancer patients, and historically, treating cancer that has spread to the brain has been particularly difficult. This is where Osimertinib has made a genuine difference.

Osimertinib and Brain Metastasis — What the Research Shows Read More »

Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide)

Leave a Comment / Blog, Osimertinib, Patient Guide / Admin

One of the most common questions patients and caregivers ask after a new prescription is simple: why this dose, and not the other one? Osimertinib is available in two strengths — 40 mg and 80 mg — and the choice between them depends on several factors specific to each patient. This guide explains how Osimertinib

Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide) Read More »

How to Access Osimertinib in India Legally — A Step-by-Step Guide

Leave a Comment / Lung Cancer, Osimertinib / Admin

One of the most common questions we receive at CBMeds is: “Is it legal to get Osimertinib from India?” The answer is yes. This guide explains exactly how it works, what documents you need, and what the process looks like from first inquiry to doorstep delivery. Whether you are a patient, a family member, or

How to Access Osimertinib in India Legally — A Step-by-Step Guide Read More »

Osimertinib Side Effects — Complete Patient Guide (2026)

Leave a Comment / Lung Cancer, Osimertinib / Admin

Starting a new cancer medicine can feel daunting, especially when you read the long list of possible side effects. This guide gives you a clear, honest picture of what to expect from Osimertinib — what is common, what is rare, what to watch out for, and how to manage side effects so they interfere as

Osimertinib Side Effects — Complete Patient Guide (2026) Read More »

EGFR Positive Lung Cancer — A Complete Guide for Patients and Families

Leave a Comment / EGFR, Lung Cancer, Osimertinib / Admin

Being told you have EGFR positive lung cancer can feel overwhelming. But here is something important to know from the start: an EGFR mutation in lung cancer is not just a diagnosis — it is a specific piece of information that opens the door to some of the most effective targeted treatments available in oncology

EGFR Positive Lung Cancer — A Complete Guide for Patients and Families Read More »

TOMORROW'S MEDICINES TODAY

Lung Cancer

Osimertinib for EGFR Mutation (T790M): Complete Patient Guide

The Hidden Cost of Cancer: More Than Just Medical Bills

Osimertinib Resistance — Causes and What Happens Next

Named Patient Medicine Explained — How Patients Legally Access Unavailable Medicines

Osimertinib and Brain Metastasis — What the Research Shows

Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide)

How to Access Osimertinib in India Legally — A Step-by-Step Guide

Osimertinib Side Effects — Complete Patient Guide (2026)

EGFR Positive Lung Cancer — A Complete Guide for Patients and Families

We are committed to the Ethical Principles of the World Medical Association.

We are registered and audited by the Dutch Ministry of Health in The Hague as an Independent Intermediary for Medicines, registration number 6730 BEM and as a Pharmaceutical Distributor with the registration number 16258 G.

We support the United Nation’s 2030 Sustainable Development Goals related to Health and Equality.

ABOUT US

MENU

SOCIAL